Digestive System Neoplasms  >>  NGC-capecitabine (PCS6422)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NGC-capecitabine (PCS6422) / Processa Pharma
NCT00004195: Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer

Completed
2
28
US
eniluracil, 5 Fu/eniluracil (eli Lilly), 5-fu/eniluracil, 5fu/eniluraci, conventional colon surgery
University of Alabama at Birmingham, National Cancer Institute (NCI), Glaxo Wellcome
Colorectal Cancer
10/99
05/01

Download Options